EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹3,642 Cr | ₹3,313 Cr | ₹2,634 Cr | ₹2,196 Cr | ₹1,695 Cr |
What is the latest Profit & Loss Account Balance ratio of EMCURE PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹3,642 Cr |
| Mar2025 | ₹3,313 Cr |
| Mar2024 | ₹2,634 Cr |
| Mar2023 | ₹2,196 Cr |
| Mar2022 | ₹1,695 Cr |
How is Profit & Loss Account Balance of EMCURE PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,642 Cr | 9.93 | |
| Mar2025 | ₹3,313 Cr | 25.78 | |
| Mar2024 | ₹2,634 Cr | 19.92 | |
| Mar2023 | ₹2,196 Cr | 29.56 | |
| Mar2022 | ₹1,695 Cr | - | |
Compare Profit & Loss Account Balance of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,899.5 Cr | -2.8% | 4.4% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.8% |
4.4% |
45.5% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses